

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.39687485 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.05238915 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.05238915 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.96853302 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.52627700 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.52627700 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.52627700 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.52627700 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.52627700 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.52627700 |
| 11 | negative regulation of cell killing (GO:0031342) | 4.49067561 |
| 12 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.49067561 |
| 13 | detection of other organism (GO:0098543) | 4.39052881 |
| 14 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.18420374 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.08651547 |
| 16 | detection of bacterium (GO:0016045) | 4.02803598 |
| 17 | detection of molecule of bacterial origin (GO:0032490) | 3.99815169 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 3.95024535 |
| 19 | regulation of tolerance induction (GO:0002643) | 3.89293954 |
| 20 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.88738494 |
| 21 | positive regulation of mast cell activation (GO:0033005) | 3.85014117 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.84503617 |
| 23 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.81704818 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.79310769 |
| 25 | myeloid dendritic cell activation (GO:0001773) | 3.79219668 |
| 26 | NIK/NF-kappaB signaling (GO:0038061) | 3.73652199 |
| 27 | regulation of T cell tolerance induction (GO:0002664) | 3.73503707 |
| 28 | regulation of mast cell degranulation (GO:0043304) | 3.68906977 |
| 29 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.65338109 |
| 30 | myeloid dendritic cell differentiation (GO:0043011) | 3.63873606 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.60744886 |
| 32 | microglial cell activation (GO:0001774) | 3.60730206 |
| 33 | defense response to protozoan (GO:0042832) | 3.56842142 |
| 34 | response to interferon-beta (GO:0035456) | 3.56333736 |
| 35 | negative regulation of growth of symbiont in host (GO:0044130) | 3.54905567 |
| 36 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 3.54905567 |
| 37 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 3.54905567 |
| 38 | regulation of growth of symbiont in host (GO:0044126) | 3.54905567 |
| 39 | positive regulation of mast cell degranulation (GO:0043306) | 3.54241981 |
| 40 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.54241981 |
| 41 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.52727635 |
| 42 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.50176910 |
| 43 | detection of biotic stimulus (GO:0009595) | 3.49314189 |
| 44 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.47134047 |
| 45 | regulation of mast cell activation (GO:0033003) | 3.44988776 |
| 46 | response to protozoan (GO:0001562) | 3.44822661 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44529380 |
| 48 | immunoglobulin mediated immune response (GO:0016064) | 3.44527101 |
| 49 | macrophage activation (GO:0042116) | 3.41939775 |
| 50 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.40641194 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.39823917 |
| 52 | leukocyte aggregation (GO:0070486) | 3.32794519 |
| 53 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28370960 |
| 54 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.27988292 |
| 55 | respiratory burst (GO:0045730) | 3.27591246 |
| 56 | negative regulation of phagocytosis (GO:0050765) | 3.27256319 |
| 57 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.25776672 |
| 58 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.24186697 |
| 59 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.24041283 |
| 60 | type I interferon signaling pathway (GO:0060337) | 3.22865602 |
| 61 | cellular response to type I interferon (GO:0071357) | 3.22865602 |
| 62 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.22364912 |
| 63 | response to host immune response (GO:0052572) | 3.22364912 |
| 64 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 3.21998949 |
| 65 | cellular response to zinc ion (GO:0071294) | 3.21310331 |
| 66 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21282936 |
| 67 | mast cell activation (GO:0045576) | 3.21055494 |
| 68 | response to type I interferon (GO:0034340) | 3.20829078 |
| 69 | dendritic cell differentiation (GO:0097028) | 3.17011325 |
| 70 | regulation of B cell differentiation (GO:0045577) | 3.12688340 |
| 71 | response to peptidoglycan (GO:0032494) | 3.12620991 |
| 72 | leukocyte degranulation (GO:0043299) | 3.11708967 |
| 73 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.10881438 |
| 74 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.10881438 |
| 75 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.10374315 |
| 76 | cellular response to interferon-beta (GO:0035458) | 3.09240046 |
| 77 | regulation of leukocyte degranulation (GO:0043300) | 3.09101824 |
| 78 | interferon-gamma production (GO:0032609) | 3.06404377 |
| 79 | response to interleukin-15 (GO:0070672) | 3.05751411 |
| 80 | T cell migration (GO:0072678) | 3.02776982 |
| 81 | B cell mediated immunity (GO:0019724) | 3.02544923 |
| 82 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.99557626 |
| 83 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.99411249 |
| 84 | neutrophil activation (GO:0042119) | 2.99023697 |
| 85 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.98794489 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.97323635 |
| 87 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.96363614 |
| 88 | positive regulation of macrophage differentiation (GO:0045651) | 2.95673288 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93759337 |
| 90 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.93104423 |
| 91 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91646092 |
| 92 | neutrophil mediated immunity (GO:0002446) | 2.90929063 |
| 93 | negative thymic T cell selection (GO:0045060) | 2.90758541 |
| 94 | T-helper 1 type immune response (GO:0042088) | 2.90669667 |
| 95 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.90240797 |
| 96 | positive thymic T cell selection (GO:0045059) | 2.89811354 |
| 97 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89645135 |
| 98 | response to host (GO:0075136) | 2.89645135 |
| 99 | response to host defenses (GO:0052200) | 2.89645135 |
| 100 | positive regulation of isotype switching (GO:0045830) | 2.88582500 |
| 101 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.88452374 |
| 102 | positive regulation of respiratory burst (GO:0060267) | 2.87980841 |
| 103 | response to fungus (GO:0009620) | 2.87966720 |
| 104 | cellular response to interleukin-15 (GO:0071350) | 2.87755400 |
| 105 | granulocyte activation (GO:0036230) | 2.87635652 |
| 106 | DNA deamination (GO:0045006) | 2.87140129 |
| 107 | regulation of RIG-I signaling pathway (GO:0039535) | 2.85540067 |
| 108 | regulation of gamma-delta T cell activation (GO:0046643) | 2.85406758 |
| 109 | germinal center formation (GO:0002467) | 2.85340347 |
| 110 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.83340834 |
| 111 | regulation of necroptotic process (GO:0060544) | 2.83335585 |
| 112 | regulation of antigen processing and presentation (GO:0002577) | 2.83082421 |
| 113 | negative regulation of interleukin-6 production (GO:0032715) | 2.82453957 |
| 114 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.82350152 |
| 115 | negative T cell selection (GO:0043383) | 2.80165066 |
| 116 | regulation of hypersensitivity (GO:0002883) | 2.79847913 |
| 117 | response to interferon-alpha (GO:0035455) | 2.79076176 |
| 118 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.78682232 |
| 119 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.78361801 |
| 120 | actin nucleation (GO:0045010) | 2.77308185 |
| 121 | regulation of natural killer cell differentiation (GO:0032823) | 2.76974790 |
| 122 | myeloid cell activation involved in immune response (GO:0002275) | 2.76279428 |
| 123 | regulation of interferon-alpha production (GO:0032647) | 2.75725425 |
| 124 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.75086656 |
| 125 | leukocyte mediated cytotoxicity (GO:0001909) | 2.72680618 |
| 126 | negative regulation of interleukin-12 production (GO:0032695) | 2.70052853 |
| 127 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.68840836 |
| 128 | necroptotic process (GO:0070266) | 2.68309324 |
| 129 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.68152205 |
| 130 | viral transcription (GO:0019083) | 2.66909202 |
| 131 | positive regulation of B cell mediated immunity (GO:0002714) | 2.66830417 |
| 132 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.66830417 |
| 133 | angiogenesis involved in wound healing (GO:0060055) | 2.65892898 |
| 134 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65148512 |
| 135 | negative regulation of viral genome replication (GO:0045071) | 2.63908419 |
| 136 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.63832980 |
| 137 | cellular extravasation (GO:0045123) | 2.63803340 |
| 138 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.63588212 |
| 139 | tolerance induction (GO:0002507) | 2.63167112 |
| 140 | myeloid leukocyte mediated immunity (GO:0002444) | 2.62217467 |
| 141 | definitive hemopoiesis (GO:0060216) | 2.61817807 |
| 142 | T cell homeostasis (GO:0043029) | 2.59662231 |
| 143 | positive regulation of interferon-alpha production (GO:0032727) | 2.59579801 |
| 144 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58850071 |
| 145 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.58081171 |
| 146 | myeloid leukocyte activation (GO:0002274) | 2.57861022 |
| 147 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.56894047 |
| 148 | regulation of chemokine biosynthetic process (GO:0045073) | 2.56617152 |
| 149 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.56583289 |
| 150 | regulation of regulatory T cell differentiation (GO:0045589) | 2.54403311 |
| 151 | translational termination (GO:0006415) | 2.54229776 |
| 152 | B cell receptor signaling pathway (GO:0050853) | 2.54204179 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.97922171 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.25155552 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.24294371 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.08500890 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.05207742 |
| 6 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.81287950 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.64421653 |
| 8 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.57905721 |
| 9 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.18171866 |
| 10 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.08219560 |
| 11 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.07680924 |
| 12 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.03043641 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87010122 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79621721 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.75957504 |
| 16 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.74031564 |
| 17 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.73531739 |
| 18 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.64044362 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.63644352 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60886907 |
| 21 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.46748495 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.35520037 |
| 23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.34257214 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32047647 |
| 25 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.20428131 |
| 26 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.12258913 |
| 27 | * VDR_24787735_ChIP-Seq_THP-1_Human | 2.06652938 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06556090 |
| 29 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.05397238 |
| 30 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.04380110 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.98771199 |
| 32 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.98315861 |
| 33 | * MAF_26560356_Chip-Seq_TH1_Human | 1.97560831 |
| 34 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.96147477 |
| 35 | MYB_26560356_Chip-Seq_TH1_Human | 1.95232044 |
| 36 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.94051151 |
| 37 | MYC_22102868_ChIP-Seq_BL_Human | 1.92021384 |
| 38 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.89141360 |
| 39 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.88941148 |
| 40 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.87577225 |
| 41 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83000184 |
| 42 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76859136 |
| 43 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.75628557 |
| 44 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74881809 |
| 45 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74526660 |
| 46 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.70907019 |
| 47 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.66738202 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.64460164 |
| 49 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.62906659 |
| 50 | GATA1_22025678_ChIP-Seq_K562_Human | 1.62118556 |
| 51 | UTX_26944678_Chip-Seq_JUKART_Human | 1.56531973 |
| 52 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.54442836 |
| 53 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.45269401 |
| 54 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.43536610 |
| 55 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43490353 |
| 56 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.41320783 |
| 57 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.41173533 |
| 58 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.38531363 |
| 59 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.37466639 |
| 60 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.35355262 |
| 61 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.35168099 |
| 62 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34074829 |
| 63 | SPI1_23127762_ChIP-Seq_K562_Human | 1.32454049 |
| 64 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.32166799 |
| 65 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.29785416 |
| 66 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.29705594 |
| 67 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.29637267 |
| 68 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28918305 |
| 69 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.27037149 |
| 70 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.26858989 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23932021 |
| 72 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22054516 |
| 73 | * MAF_26560356_Chip-Seq_TH2_Human | 1.21906633 |
| 74 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.20267173 |
| 75 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19124236 |
| 76 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16537235 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.15911856 |
| 78 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.15289545 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.14266462 |
| 80 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.13384116 |
| 81 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.13371500 |
| 82 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.12568194 |
| 83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12416088 |
| 84 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.10529633 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09524156 |
| 86 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08387656 |
| 87 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08355040 |
| 88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08002927 |
| 89 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.07011938 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06687715 |
| 91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06606193 |
| 92 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05279765 |
| 93 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.04033707 |
| 94 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.03652674 |
| 95 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02255054 |
| 96 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98563247 |
| 97 | GATA2_19941826_ChIP-Seq_K562_Human | 0.96456342 |
| 98 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.94581011 |
| 99 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.93934133 |
| 100 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93043953 |
| 101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.92492733 |
| 102 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.92176424 |
| 103 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89991344 |
| 104 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.86207156 |
| 105 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86038626 |
| 106 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.85854845 |
| 107 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.85370121 |
| 108 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.84811938 |
| 109 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83816309 |
| 110 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.83514743 |
| 111 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83229728 |
| 112 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.82789845 |
| 113 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81600531 |
| 114 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.81345799 |
| 115 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.80976559 |
| 116 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.80585258 |
| 117 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.80368262 |
| 118 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79761962 |
| 119 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.79601832 |
| 120 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.79579965 |
| 121 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.78467001 |
| 122 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77447886 |
| 123 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71332780 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.71199858 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.61023965 |
| 2 | MP0005671_abnormal_response_to | 3.73710731 |
| 3 | MP0009785_altered_susceptibility_to | 3.57800425 |
| 4 | MP0000685_abnormal_immune_system | 3.56668141 |
| 5 | MP0002148_abnormal_hypersensitivity_rea | 3.16129600 |
| 6 | MP0003436_decreased_susceptibility_to | 3.12587825 |
| 7 | MP0005000_abnormal_immune_tolerance | 2.88594042 |
| 8 | MP0003724_increased_susceptibility_to | 2.87526816 |
| 9 | MP0005025_abnormal_response_to | 2.86080924 |
| 10 | MP0001800_abnormal_humoral_immune | 2.71916341 |
| 11 | MP0005387_immune_system_phenotype | 2.71191560 |
| 12 | MP0001790_abnormal_immune_system | 2.71191560 |
| 13 | MP0002419_abnormal_innate_immunity | 2.64161002 |
| 14 | MP0003763_abnormal_thymus_physiology | 2.56405232 |
| 15 | MP0002452_abnormal_antigen_presenting | 2.55458968 |
| 16 | MP0003303_peritoneal_inflammation | 2.53591448 |
| 17 | MP0002723_abnormal_immune_serum | 2.51344920 |
| 18 | MP0002396_abnormal_hematopoietic_system | 2.50204113 |
| 19 | MP0002420_abnormal_adaptive_immunity | 2.44978514 |
| 20 | MP0001819_abnormal_immune_cell | 2.44202796 |
| 21 | MP0006082_CNS_inflammation | 2.33595329 |
| 22 | MP0002166_altered_tumor_susceptibility | 2.29950959 |
| 23 | MP0001873_stomach_inflammation | 2.26546650 |
| 24 | MP0001853_heart_inflammation | 2.20361277 |
| 25 | MP0005464_abnormal_platelet_physiology | 2.18051659 |
| 26 | MP0002398_abnormal_bone_marrow | 2.16868248 |
| 27 | MP0002405_respiratory_system_inflammati | 2.08796492 |
| 28 | MP0009333_abnormal_splenocyte_physiolog | 2.02974399 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.02099273 |
| 30 | * MP0000716_abnormal_immune_system | 2.00803384 |
| 31 | MP0002006_tumorigenesis | 1.97495727 |
| 32 | MP0004510_myositis | 1.96203642 |
| 33 | MP0005397_hematopoietic_system_phenotyp | 1.91204654 |
| 34 | MP0001545_abnormal_hematopoietic_system | 1.91204654 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.81822954 |
| 36 | MP0002254_reproductive_system_inflammat | 1.78122773 |
| 37 | MP0002722_abnormal_immune_system | 1.74031276 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.72227799 |
| 39 | * MP0002429_abnormal_blood_cell | 1.71728616 |
| 40 | MP0000465_gastrointestinal_hemorrhage | 1.70991395 |
| 41 | MP0005310_abnormal_salivary_gland | 1.67853040 |
| 42 | MP0004808_abnormal_hematopoietic_stem | 1.67458144 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.64426919 |
| 44 | MP0000490_abnormal_crypts_of | 1.57018468 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.52329507 |
| 46 | MP0005174_abnormal_tail_pigmentation | 1.46432129 |
| 47 | MP0000343_altered_response_to | 1.44851943 |
| 48 | MP0004947_skin_inflammation | 1.44537947 |
| 49 | MP0000858_altered_metastatic_potential | 1.42837326 |
| 50 | MP0008469_abnormal_protein_level | 1.42670377 |
| 51 | MP0000569_abnormal_digit_pigmentation | 1.41599625 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.39042160 |
| 53 | MP0008260_abnormal_autophagy | 1.36554236 |
| 54 | MP0003866_abnormal_defecation | 1.33738177 |
| 55 | MP0001348_abnormal_lacrimal_gland | 1.29883610 |
| 56 | MP0002138_abnormal_hepatobiliary_system | 1.26771298 |
| 57 | MP0003448_altered_tumor_morphology | 1.24619693 |
| 58 | MP0009764_decreased_sensitivity_to | 1.24002235 |
| 59 | MP0008057_abnormal_DNA_replication | 1.23892616 |
| 60 | MP0006054_spinal_hemorrhage | 1.18887035 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.12498377 |
| 62 | MP0005451_abnormal_body_composition | 1.09606000 |
| 63 | MP0003172_abnormal_lysosome_physiology | 1.08130232 |
| 64 | MP0009278_abnormal_bone_marrow | 1.07515982 |
| 65 | MP0004883_abnormal_blood_vessel | 1.03189352 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 1.02581611 |
| 67 | MP0002933_joint_inflammation | 1.01020418 |
| 68 | MP0004381_abnormal_hair_follicle | 0.96489213 |
| 69 | MP0000604_amyloidosis | 0.96008585 |
| 70 | MP0001663_abnormal_digestive_system | 0.95845161 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 0.93583471 |
| 72 | MP0010307_abnormal_tumor_latency | 0.93021630 |
| 73 | MP0001851_eye_inflammation | 0.92679730 |
| 74 | MP0002998_abnormal_bone_remodeling | 0.92539290 |
| 75 | MP0002019_abnormal_tumor_incidence | 0.92493752 |
| 76 | MP0008007_abnormal_cellular_replicative | 0.91716975 |
| 77 | MP0003693_abnormal_embryo_hatching | 0.91527987 |
| 78 | MP0003075_altered_response_to | 0.88569434 |
| 79 | MP0008004_abnormal_stomach_pH | 0.88217602 |
| 80 | MP0002277_abnormal_respiratory_mucosa | 0.88060504 |
| 81 | MP0002095_abnormal_skin_pigmentation | 0.85800878 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 0.85370916 |
| 83 | MP0009840_abnormal_foam_cell | 0.84084936 |
| 84 | MP0009763_increased_sensitivity_to | 0.79992614 |
| 85 | MP0003045_fibrosis | 0.78394048 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.78072217 |
| 87 | MP0010352_gastrointestinal_tract_polyps | 0.77457870 |
| 88 | MP0000249_abnormal_blood_vessel | 0.76771763 |
| 89 | MP0003690_abnormal_glial_cell | 0.76114549 |
| 90 | MP0010094_abnormal_chromosome_stability | 0.74763114 |
| 91 | MP0005167_abnormal_blood-brain_barrier | 0.74478806 |
| 92 | MP0003828_pulmonary_edema | 0.74320013 |
| 93 | MP0005076_abnormal_cell_differentiation | 0.74105107 |
| 94 | MP0003186_abnormal_redox_activity | 0.74099863 |
| 95 | MP0005390_skeleton_phenotype | 0.71924451 |
| 96 | MP0005166_decreased_susceptibility_to | 0.71595837 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.70361612 |
| 98 | MP0002009_preneoplasia | 0.69114230 |
| 99 | MP0000015_abnormal_ear_pigmentation | 0.65688834 |
| 100 | MP0003077_abnormal_cell_cycle | 0.64439440 |
| 101 | MP0005164_abnormal_response_to | 0.64221612 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.63473471 |
| 103 | MP0003795_abnormal_bone_structure | 0.60594951 |
| 104 | MP0005319_abnormal_enzyme/_coenzyme | 0.60210514 |
| 105 | MP0002132_abnormal_respiratory_system | 0.59535952 |
| 106 | MP0003221_abnormal_cardiomyocyte_apopto | 0.58299606 |
| 107 | MP0000313_abnormal_cell_death | 0.57786384 |
| 108 | MP0008058_abnormal_DNA_repair | 0.57626533 |
| 109 | MP0001881_abnormal_mammary_gland | 0.55137352 |
| 110 | MP0002332_abnormal_exercise_endurance | 0.54651961 |
| 111 | MP0003656_abnormal_erythrocyte_physiolo | 0.54584893 |
| 112 | MP0000681_abnormal_thyroid_gland | 0.53064091 |
| 113 | MP0009765_abnormal_xenobiotic_induced | 0.52797565 |
| 114 | MP0001764_abnormal_homeostasis | 0.52293345 |
| 115 | MP0001986_abnormal_taste_sensitivity | 0.52239739 |
| 116 | MP0003091_abnormal_cell_migration | 0.52191493 |
| 117 | MP0008874_decreased_physiological_sensi | 0.50625098 |
| 118 | MP0008873_increased_physiological_sensi | 0.50501599 |
| 119 | MP0000371_diluted_coat_color | 0.50344717 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.15238778 |
| 2 | Myositis (HP:0100614) | 5.13324779 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.00596805 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.73692178 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.59427247 |
| 6 | Thrombocytosis (HP:0001894) | 4.57264982 |
| 7 | Retrobulbar optic neuritis (HP:0100654) | 4.30105365 |
| 8 | Optic neuritis (HP:0100653) | 4.30105365 |
| 9 | Orchitis (HP:0100796) | 4.22816670 |
| 10 | Petechiae (HP:0000967) | 4.00608177 |
| 11 | Recurrent fungal infections (HP:0002841) | 3.94169831 |
| 12 | Chronic otitis media (HP:0000389) | 3.81037674 |
| 13 | Obstructive lung disease (HP:0006536) | 3.73098469 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.73098469 |
| 15 | IgM deficiency (HP:0002850) | 3.62638066 |
| 16 | Mediastinal lymphadenopathy (HP:0100721) | 3.53326056 |
| 17 | Vasculitis (HP:0002633) | 3.48393823 |
| 18 | Meningitis (HP:0001287) | 3.45766122 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.40953338 |
| 20 | Recurrent skin infections (HP:0001581) | 3.40347363 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.39660797 |
| 22 | Recurrent viral infections (HP:0004429) | 3.38867889 |
| 23 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.35679799 |
| 24 | Recurrent cutaneous fungal infections (HP:0011370) | 3.35679799 |
| 25 | Stomatitis (HP:0010280) | 3.30149824 |
| 26 | Aplastic anemia (HP:0001915) | 3.29801688 |
| 27 | Abnormality of the prostate (HP:0008775) | 3.29198420 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.27010238 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.22440113 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.21071020 |
| 31 | Pulmonary infiltrates (HP:0002113) | 3.20241408 |
| 32 | Amyloidosis (HP:0011034) | 3.17873169 |
| 33 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.11746839 |
| 34 | Keratoconjunctivitis (HP:0001096) | 3.08040929 |
| 35 | Hemoptysis (HP:0002105) | 3.04344466 |
| 36 | Abnormality of T cells (HP:0002843) | 2.97753483 |
| 37 | Arterial thrombosis (HP:0004420) | 2.97434727 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.97028779 |
| 39 | Keratoconjunctivitis sicca (HP:0001097) | 2.91308686 |
| 40 | Prolonged bleeding time (HP:0003010) | 2.90425916 |
| 41 | Epistaxis (HP:0000421) | 2.86023169 |
| 42 | Increased IgM level (HP:0003496) | 2.79258438 |
| 43 | Abnormality of glycolipid metabolism (HP:0010969) | 2.78527989 |
| 44 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.78527989 |
| 45 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.78527989 |
| 46 | IgG deficiency (HP:0004315) | 2.77442633 |
| 47 | Hypergammaglobulinemia (HP:0010702) | 2.76133746 |
| 48 | Vacuolated lymphocytes (HP:0001922) | 2.76083945 |
| 49 | Purpura (HP:0000979) | 2.74429768 |
| 50 | Chest pain (HP:0100749) | 2.73722886 |
| 51 | Gingival bleeding (HP:0000225) | 2.73552705 |
| 52 | Abnormality of B cell number (HP:0010975) | 2.73109953 |
| 53 | B lymphocytopenia (HP:0010976) | 2.73109953 |
| 54 | Leukocytosis (HP:0001974) | 2.71012503 |
| 55 | Eosinophilia (HP:0001880) | 2.70343779 |
| 56 | Cellulitis (HP:0100658) | 2.69156473 |
| 57 | Nasal polyposis (HP:0100582) | 2.68387099 |
| 58 | Periodontitis (HP:0000704) | 2.67004977 |
| 59 | Abnormality of T cell number (HP:0011839) | 2.66518106 |
| 60 | Increased cerebral lipofuscin (HP:0011813) | 2.66040227 |
| 61 | Reduced antithrombin III activity (HP:0001976) | 2.64976401 |
| 62 | Encephalitis (HP:0002383) | 2.64584489 |
| 63 | Granulocytopenia (HP:0001913) | 2.60893393 |
| 64 | Abnormality of eosinophils (HP:0001879) | 2.59204600 |
| 65 | Gastrointestinal infarctions (HP:0005244) | 2.58003811 |
| 66 | Interstitial pulmonary disease (HP:0006530) | 2.57690352 |
| 67 | Spontaneous hematomas (HP:0007420) | 2.56753638 |
| 68 | Abnormal number of erythroid precursors (HP:0012131) | 2.56389079 |
| 69 | Abnormality of the nasal mucosa (HP:0000433) | 2.54463281 |
| 70 | Episodic fever (HP:0001954) | 2.54164235 |
| 71 | Gangrene (HP:0100758) | 2.52361112 |
| 72 | Agammaglobulinemia (HP:0004432) | 2.51459116 |
| 73 | Reticulocytopenia (HP:0001896) | 2.51121123 |
| 74 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.48228203 |
| 75 | Anorexia (HP:0002039) | 2.46963817 |
| 76 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46871492 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.44330348 |
| 78 | T lymphocytopenia (HP:0005403) | 2.42907141 |
| 79 | Colitis (HP:0002583) | 2.42767909 |
| 80 | Lymphopenia (HP:0001888) | 2.41299326 |
| 81 | Severe combined immunodeficiency (HP:0004430) | 2.40332517 |
| 82 | Autoimmune hemolytic anemia (HP:0001890) | 2.39651810 |
| 83 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38208043 |
| 84 | Gastrointestinal inflammation (HP:0004386) | 2.37306577 |
| 85 | Gingivitis (HP:0000230) | 2.34337597 |
| 86 | Pustule (HP:0200039) | 2.33071833 |
| 87 | Hepatosplenomegaly (HP:0001433) | 2.28498826 |
| 88 | Impaired platelet aggregation (HP:0003540) | 2.28307502 |
| 89 | Abnormal platelet function (HP:0011869) | 2.28307502 |
| 90 | Pulmonary embolism (HP:0002204) | 2.26841255 |
| 91 | Dysostosis multiplex (HP:0000943) | 2.26594755 |
| 92 | Osteomyelitis (HP:0002754) | 2.25828574 |
| 93 | Thrombophlebitis (HP:0004418) | 2.25796018 |
| 94 | Increased serum ferritin (HP:0003281) | 2.25022831 |
| 95 | Skin rash (HP:0000988) | 2.23081327 |
| 96 | Increased IgE level (HP:0003212) | 2.21595743 |
| 97 | Thyroiditis (HP:0100646) | 2.21128444 |
| 98 | Urticaria (HP:0001025) | 2.20577789 |
| 99 | Amaurosis fugax (HP:0100576) | 2.20228497 |
| 100 | Combined immunodeficiency (HP:0005387) | 2.18989101 |
| 101 | Hypochromic anemia (HP:0001931) | 2.18890411 |
| 102 | Systemic lupus erythematosus (HP:0002725) | 2.17871329 |
| 103 | Abnormality of the pleura (HP:0002103) | 2.17622174 |
| 104 | IgA deficiency (HP:0002720) | 2.17196017 |
| 105 | Hypochromic microcytic anemia (HP:0004840) | 2.15953174 |
| 106 | Type I transferrin isoform profile (HP:0003642) | 2.15556290 |
| 107 | Loss of speech (HP:0002371) | 2.14733340 |
| 108 | Gastrointestinal stroma tumor (HP:0100723) | 2.13504144 |
| 109 | Skin ulcer (HP:0200042) | 2.11741326 |
| 110 | Lymphoma (HP:0002665) | 2.10739872 |
| 111 | Sepsis (HP:0100806) | 2.10609591 |
| 112 | Abnormality of iron homeostasis (HP:0011031) | 2.09383913 |
| 113 | Basal ganglia calcification (HP:0002135) | 2.09318683 |
| 114 | Pulmonary fibrosis (HP:0002206) | 2.07844383 |
| 115 | Abnormality of the pericardium (HP:0001697) | 2.07808433 |
| 116 | Neutropenia (HP:0001875) | 2.07765676 |
| 117 | Recurrent pneumonia (HP:0006532) | 2.07431502 |
| 118 | Acute myeloid leukemia (HP:0004808) | 2.07413811 |
| 119 | Restrictive lung disease (HP:0002091) | 2.07222170 |
| 120 | Polyneuropathy (HP:0001271) | 2.06341768 |
| 121 | Joint swelling (HP:0001386) | 2.06315268 |
| 122 | Spondylolisthesis (HP:0003302) | 2.04867354 |
| 123 | Vertigo (HP:0002321) | 2.04128406 |
| 124 | Glomerulopathy (HP:0100820) | 2.03727104 |
| 125 | Chronic diarrhea (HP:0002028) | 2.02996056 |
| 126 | Arthralgia (HP:0002829) | 2.02541779 |
| 127 | Acute hepatic failure (HP:0006554) | 2.00019581 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 4.23795275 |
| 2 | MAP4K1 | 3.48204359 |
| 3 | MAP3K14 | 3.36295895 |
| 4 | IRAK4 | 2.94134460 |
| 5 | KIT | 2.73855657 |
| 6 | JAK3 | 2.73555970 |
| 7 | TBK1 | 2.61012761 |
| 8 | TEC | 2.54844364 |
| 9 | PIM2 | 2.44583346 |
| 10 | BLK | 2.43013233 |
| 11 | IKBKE | 2.36148630 |
| 12 | PRPF4B | 2.33213693 |
| 13 | TYK2 | 2.30741936 |
| 14 | BTK | 2.23881658 |
| 15 | ZAP70 | 2.15409942 |
| 16 | IKBKB | 2.10137694 |
| 17 | IRAK3 | 1.96543296 |
| 18 | NME2 | 1.81375014 |
| 19 | SYK | 1.73294056 |
| 20 | MAP3K12 | 1.58781228 |
| 21 | PIM1 | 1.50318509 |
| 22 | TAOK3 | 1.50237895 |
| 23 | ITK | 1.44935651 |
| 24 | FGR | 1.44731510 |
| 25 | STK16 | 1.38626791 |
| 26 | MAP2K3 | 1.38571675 |
| 27 | FLT3 | 1.36977082 |
| 28 | JAK1 | 1.35833277 |
| 29 | KDR | 1.34639116 |
| 30 | RIPK4 | 1.34136487 |
| 31 | CHUK | 1.30444318 |
| 32 | TGFBR2 | 1.29409860 |
| 33 | NLK | 1.23125536 |
| 34 | TGFBR1 | 1.21930660 |
| 35 | LCK | 1.21114162 |
| 36 | CSF1R | 1.19950911 |
| 37 | TAOK1 | 1.19175185 |
| 38 | MAP3K3 | 1.16295870 |
| 39 | GRK7 | 1.14648264 |
| 40 | MATK | 1.14528987 |
| 41 | TAOK2 | 1.14509380 |
| 42 | LYN | 1.13583681 |
| 43 | EIF2AK3 | 1.09437504 |
| 44 | HCK | 1.08782731 |
| 45 | MAP3K6 | 1.06051711 |
| 46 | MAP3K13 | 1.05877039 |
| 47 | IRAK2 | 1.01603309 |
| 48 | ACVR1B | 1.00763598 |
| 49 | STK10 | 1.00522473 |
| 50 | FES | 1.00120693 |
| 51 | MAP3K1 | 0.99766985 |
| 52 | MST4 | 0.98688526 |
| 53 | RPS6KA4 | 0.98344882 |
| 54 | ERN1 | 0.94899758 |
| 55 | EEF2K | 0.94274225 |
| 56 | JAK2 | 0.89985363 |
| 57 | CSK | 0.86619839 |
| 58 | EPHB1 | 0.86206262 |
| 59 | LRRK2 | 0.85261068 |
| 60 | GRK6 | 0.85041500 |
| 61 | VRK1 | 0.83945776 |
| 62 | SCYL2 | 0.82682444 |
| 63 | PDK1 | 0.80048925 |
| 64 | FGFR3 | 0.79331521 |
| 65 | MOS | 0.78436480 |
| 66 | CLK1 | 0.75783257 |
| 67 | WEE1 | 0.74171966 |
| 68 | NEK9 | 0.73941290 |
| 69 | EIF2AK1 | 0.73479150 |
| 70 | EIF2AK2 | 0.72819607 |
| 71 | TRPM7 | 0.71370278 |
| 72 | TNIK | 0.71046158 |
| 73 | MAP3K5 | 0.70611481 |
| 74 | KSR2 | 0.70605347 |
| 75 | YES1 | 0.68465237 |
| 76 | FGFR4 | 0.66916688 |
| 77 | MYLK | 0.66567359 |
| 78 | RPS6KB2 | 0.66335733 |
| 79 | STK4 | 0.61027891 |
| 80 | MKNK1 | 0.60074990 |
| 81 | IRAK1 | 0.59334771 |
| 82 | PDPK1 | 0.58905755 |
| 83 | MAPKAPK3 | 0.58395900 |
| 84 | HIPK2 | 0.58321953 |
| 85 | TIE1 | 0.57816978 |
| 86 | SIK3 | 0.57027814 |
| 87 | BRSK2 | 0.56468528 |
| 88 | EPHA3 | 0.55533410 |
| 89 | TESK2 | 0.54124781 |
| 90 | PAK4 | 0.52350011 |
| 91 | MAPKAPK2 | 0.51674480 |
| 92 | BMPR2 | 0.50706416 |
| 93 | FYN | 0.50581206 |
| 94 | MAPK7 | 0.50246083 |
| 95 | MAPK12 | 0.49444667 |
| 96 | MAPKAPK5 | 0.49008674 |
| 97 | MAP3K11 | 0.47892821 |
| 98 | MARK3 | 0.47561538 |
| 99 | MAPK4 | 0.46764619 |
| 100 | CDK4 | 0.46751603 |
| 101 | DYRK3 | 0.44584026 |
| 102 | CDK8 | 0.44483432 |
| 103 | PRKCD | 0.44286217 |
| 104 | PIK3CG | 0.43096107 |
| 105 | CDK19 | 0.42957909 |
| 106 | TNK2 | 0.42447376 |
| 107 | NEK2 | 0.42266092 |
| 108 | MAP3K2 | 0.42068694 |
| 109 | RPS6KA6 | 0.41802118 |
| 110 | STK24 | 0.41800484 |
| 111 | MARK2 | 0.41717579 |
| 112 | ATR | 0.41071490 |
| 113 | RAF1 | 0.40890689 |
| 114 | BMPR1B | 0.40338363 |
| 115 | TLK1 | 0.40337912 |
| 116 | ABL2 | 0.39936260 |
| 117 | RPS6KA5 | 0.39835460 |
| 118 | ABL1 | 0.38533683 |
| 119 | ADRBK2 | 0.38362537 |
| 120 | RPS6KC1 | 0.37678879 |
| 121 | RPS6KL1 | 0.37678879 |
| 122 | CDK6 | 0.36982831 |
| 123 | TESK1 | 0.36915907 |
| 124 | PRKCQ | 0.35762527 |
| 125 | PRKG2 | 0.35330739 |
| 126 | SIK2 | 0.35209579 |
| 127 | MAP2K6 | 0.33887483 |
| 128 | DAPK2 | 0.33570830 |
| 129 | MAP2K2 | 0.29142953 |
| 130 | CAMKK2 | 0.29039920 |
| 131 | MAP2K4 | 0.26254576 |
| 132 | RET | 0.24189303 |
| 133 | EGFR | 0.23170707 |
| 134 | MAPK3 | 0.22646512 |
| 135 | WNK1 | 0.22542887 |
| 136 | INSR | 0.20809663 |
| 137 | CDC42BPA | 0.17894181 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 3.26421566 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85028376 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.83185899 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.82618585 |
| 5 | Asthma_Homo sapiens_hsa05310 | 2.74993656 |
| 6 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.56877712 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.49712897 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.47631617 |
| 9 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.44449321 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.19587680 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17934878 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.12370299 |
| 13 | DNA replication_Homo sapiens_hsa03030 | 2.07533956 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 2.06727382 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.02087058 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.95812496 |
| 17 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.93367694 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.89399245 |
| 19 | Legionellosis_Homo sapiens_hsa05134 | 1.88770889 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76146479 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.70631002 |
| 22 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.66649565 |
| 23 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.63628731 |
| 24 | Pertussis_Homo sapiens_hsa05133 | 1.59310224 |
| 25 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.54352597 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.51793904 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.51160180 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.43146155 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42885423 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.36737555 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.35010681 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.33664392 |
| 33 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32984387 |
| 34 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.31542483 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.28103069 |
| 36 | Base excision repair_Homo sapiens_hsa03410 | 1.28069537 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.26653789 |
| 38 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.24920051 |
| 39 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21573863 |
| 40 | Mismatch repair_Homo sapiens_hsa03430 | 1.20537311 |
| 41 | Salmonella infection_Homo sapiens_hsa05132 | 1.20315340 |
| 42 | Homologous recombination_Homo sapiens_hsa03440 | 1.17683345 |
| 43 | Proteasome_Homo sapiens_hsa03050 | 1.14430158 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.12536412 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.07500777 |
| 46 | Hepatitis B_Homo sapiens_hsa05161 | 1.06700420 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.05279389 |
| 48 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04708083 |
| 49 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.04664581 |
| 50 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.99054280 |
| 51 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.95426480 |
| 52 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.94888836 |
| 53 | Protein export_Homo sapiens_hsa03060 | 0.94541035 |
| 54 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.92872753 |
| 55 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.91098410 |
| 56 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.89372558 |
| 57 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88298824 |
| 58 | Lysosome_Homo sapiens_hsa04142 | 0.85572563 |
| 59 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.85440415 |
| 60 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80358549 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.80116744 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 0.78856144 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.77840953 |
| 64 | Spliceosome_Homo sapiens_hsa03040 | 0.75332812 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.74328291 |
| 66 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.72750646 |
| 67 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.72423917 |
| 68 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.71907406 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.66158524 |
| 70 | Phagosome_Homo sapiens_hsa04145 | 0.64934362 |
| 71 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.64158609 |
| 72 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.63686295 |
| 73 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61485678 |
| 74 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.61205640 |
| 75 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.61105731 |
| 76 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60259329 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60211709 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.59998416 |
| 79 | HTLV-I infection_Homo sapiens_hsa05166 | 0.59592605 |
| 80 | RNA polymerase_Homo sapiens_hsa03020 | 0.58603289 |
| 81 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57116196 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.56515497 |
| 83 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.56338532 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.55132492 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55096428 |
| 86 | RNA degradation_Homo sapiens_hsa03018 | 0.52878472 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51475327 |
| 88 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.50271036 |
| 89 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.49906160 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.47445209 |
| 91 | Cell cycle_Homo sapiens_hsa04110 | 0.46674156 |
| 92 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46497574 |
| 93 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44035558 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.43384443 |
| 95 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40696818 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40051843 |
| 97 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39969184 |
| 98 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39481561 |
| 99 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.39202697 |
| 100 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.39131578 |
| 101 | Endocytosis_Homo sapiens_hsa04144 | 0.37812919 |
| 102 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36444864 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36255551 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.35853955 |
| 105 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.35054850 |
| 106 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.34628734 |
| 107 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33869264 |
| 108 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.32961355 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32472000 |
| 110 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31922680 |
| 111 | Bladder cancer_Homo sapiens_hsa05219 | 0.30700584 |
| 112 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.29894223 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.28692744 |
| 114 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.27636446 |
| 115 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.27537921 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26093527 |
| 117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.26003644 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25610915 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.23260979 |
| 120 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.22873154 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22793020 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.21941343 |
| 123 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20583827 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.19483695 |
| 125 | Alcoholism_Homo sapiens_hsa05034 | 0.17667474 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.16525551 |
| 127 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.15995201 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.15379976 |
| 129 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.15264646 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.14689439 |

